Duration of immunity, efficacy and safety in sheep of a recombinant Taenia ovis vaccine formulated with saponin or selected adjuvants
- 17 September 1999
- journal article
- clinical trial
- Published by Elsevier in Veterinary Immunology and Immunopathology
- Vol. 70 (3-4) , 161-172
- https://doi.org/10.1016/s0165-2427(99)00039-2
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- The use of recombinant ovine IL‐1β and TNF‐α as natural adjuvants and their physiological effects in vivoImmunology & Cell Biology, 1998
- Adjuvants—a classification and review of their modes of actionPublished by Elsevier ,1998
- Host‐protective fragments and antibody binding epitopes of the Taenia ovis 45W recombinant antigenParasite Immunology, 1996
- Pilot field trial of a recombinantTaenia ovisvaccine in lambs exposed to natural infectionNew Zealand Veterinary Journal, 1996
- Parasite vaccine development: large-scale recovery of immunogenic Taenia ovis fusion protein GST-45W(B/X) from Escherichia coli inclusion bodiesZeitschrift Fur Parasitenkunde-Parasitology Research, 1996
- Immune responses associated with protection in sheep vaccinated with a recombinant antigen from Taenia ovisParasite Immunology, 1996
- Identification and cDNA cloning of two novel low molecular weight host-protective antigens from Taenia ovis oncospheresInternational Journal for Parasitology, 1996
- Adjuvants for anti-parasite vaccinesParasitology Today, 1989
- Synergistic effect of detergents and aluminium phosphate on the humoral immune response to bacterial and viral membrane proteinsVaccine, 1987
- Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped virusesNature, 1984